Stem Cells Of Type 1 Diabetes Patients Transformed Into Insulin-Secreting Beta Cells; Research May Lead To New … – Medical Daily
Medical Daily |
Stem Cells Of Type 1 Diabetes Patients Transformed Into Insulin-Secreting Beta Cells; Research May Lead To New …
Medical Daily The most recent attempt to take down diabetes comes from researchers at Washington University School of Medicine in St. Louis and Harvard University, who have managed to change stem cells derived from diabetes patients into insulin–secreting cells. Diabetes Treatment Using Stem Cells: No More Insulin Injection Gene Therapy for Type 1 Diabetes: Preclinical Promise |
BioPharma-Reporter.com |
Daiichi snaps up Japanese rights to CVD stem–cell therapy
BioPharma Dive Japanese drugmaker Daiichi Sankyo has bought rights to market U.K.-based Cell Therapy’s regenerative heart treatment in Japan, boosting the profile of the stem cell therapy company. Cell Therapy, founded by Nobel Prize-winner Martin Evans, will receive … Daiichi Sankyo licenses off-the-shelf regenerative heart cell therapy from CTL Cell Therapy licenses heart failure therapy in Japan Cell Therapy Ltd’s CEO Ajan Reginald talks to TPL’s Katie Osborne |
Science Daily |
Why lab-made stem cells might fail: Errors in DNA folding
Science Daily Induced pluripotent stem cells hold promise for regenerative medicine because they can, in theory, turn into any type of tissue and because they are made from a patient’s own adult cells, guaranteeing compatibility. However, the technique that turns … Why lab-made stem cells sometimes fail |
|
Stem cell gene therapy for fatal childhood disease ready for human trial
Science Daily Dr Brian Bigger, who leads the Stem Cell and Neurotherapies Laboratory at The University of Manchester and developed the technique in partnership with the Trust scientists said: “This license agreement with Orchard will allow us to take the technique … |
Medical Xpress |
Stem cell gene therapy for fatal childhood disease ready for human trial
Medical Xpress Dr Brian Bigger, who leads the Stem Cell and Neurotherapies Laboratory at The University of Manchester and developed the technique in partnership with the Trust scientists, said: “This license agreement with Orchard will allow us to take the technique … |